Table 4.
Phase I | Phase II | Adjusted Difference (p‐value) | |
---|---|---|---|
Annualized hospitalizations, number per person per year | |||
Treatment | 0.632 | 0.614 | −0.018 (.86) |
Control | 0.825 | 0.544 | −0.281 (.009***) |
Adjusted difference (p‐value) | −0.193 (0.06*) | 0.069 (0.44) | 0.262 (.05*) |
Annualized outpatient emergency department visits, per person per year | |||
Treatment | 0.415 | 0.766 | 0.351 (<.001***) |
Control | 0.663 | 0.739 | 0.075 (.45) |
Adjusted difference (p‐value) | −0.248 (0.009***) | 0.027 (0.74) | 0.276 (.03**) |
Sample sizes | |||
Treatment | 188 | 241 | |
Control | 178 | 242 | |
Combined | 366 | 483 |
The control group means in Phase I of the demonstration are weighted but not regression‐adjusted. The means for the treatment group in Phase I and the means for both the treatment and control groups in Phase II are calculated by adding appropriate coefficient(s) from the regression model (described in text) to the Phase I control group mean.
*p < .10, **p < .05, ***p < .01.